Oct. 18 at 10:55 PM
$TRAW FDA needs to give animal rule to Tivoxavir, and fast. There is no treatments for highly pathogenic avian influenza H5N1, and it have 50% mortality. Even in the absence of human-to-human transmission, an alternative with demonstrated efficacy in three gold-standard preclinical animal models and established safety in humans is urgently needed.
